Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells

Journal article

Peer reviewed

M. R Bishop, J. D Jackson, B O'KANE-MURPHY, K SCHMIT-POKORNY, J. M Vose, P. J Bierman, P. I Warkentin, J. O Armitage, L Garrison and A Kessinger

Journal of clinical oncology, Vol.14(9), pp.2521-2526

09/01/1996

PMID: 8823331

Abstract

Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy

Biological and medical sciences

Bone marrow, stem cells transplantation. Graft versus host reaction

Medical sciences

Transfusions. Complications. Transfusion reactions. Cell and gene therapy

1 Record Views

Title: Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells
Creators: M. R Bishop - University of Nebraska Medical Center
J. D Jackson - University of Nebraska Medical Center
B O'KANE-MURPHY - University of Nebraska Medical Center
K SCHMIT-POKORNY - University of Nebraska Medical Center
J. M Vose - University of Nebraska Medical Center
P. J Bierman - University of Nebraska Medical Center
P. I Warkentin - University of Nebraska Medical Center
J. O Armitage - University of Nebraska Medical Center
L Garrison - University of Nebraska Medical Center
A Kessinger - University of Nebraska Medical Center
Publication Details: Journal of clinical oncology, Vol.14(9), pp.2521-2526
Publisher: Lippincott Williams & Wilkins
Identifiers: 991005987762802656
Academic Unit: Oral Biology
Language: English
Resource Type: Journal article